NO137500C - Analogifremgangsmaate til fremstilling av 2-amino-2`, 6`-propion-xylidid til bruk som legemiddel mot hjerte-arytmi - Google Patents

Analogifremgangsmaate til fremstilling av 2-amino-2`, 6`-propion-xylidid til bruk som legemiddel mot hjerte-arytmi

Info

Publication number
NO137500C
NO137500C NO2662/72A NO266272A NO137500C NO 137500 C NO137500 C NO 137500C NO 2662/72 A NO2662/72 A NO 2662/72A NO 266272 A NO266272 A NO 266272A NO 137500 C NO137500 C NO 137500C
Authority
NO
Norway
Prior art keywords
rhythmia
xylidide
propion
heart
medicine
Prior art date
Application number
NO2662/72A
Other languages
English (en)
Norwegian (no)
Other versions
NO137500B (no
Inventor
Robert Nichol Boyes
Benjamin R Duce
Emil R Smith
Eugene W Byrnes
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of NO137500B publication Critical patent/NO137500B/no
Publication of NO137500C publication Critical patent/NO137500C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO2662/72A 1971-07-28 1972-07-25 Analogifremgangsmaate til fremstilling av 2-amino-2`, 6`-propion-xylidid til bruk som legemiddel mot hjerte-arytmi NO137500C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16703171A 1971-07-28 1971-07-28

Publications (2)

Publication Number Publication Date
NO137500B NO137500B (no) 1977-11-28
NO137500C true NO137500C (no) 1978-03-08

Family

ID=22605664

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2662/72A NO137500C (no) 1971-07-28 1972-07-25 Analogifremgangsmaate til fremstilling av 2-amino-2`, 6`-propion-xylidid til bruk som legemiddel mot hjerte-arytmi

Country Status (23)

Country Link
JP (1) JPS565220B1 (fi)
AR (1) AR193748A1 (fi)
AT (1) AT317185B (fi)
AU (1) AU476000B2 (fi)
BE (1) BE786875A (fi)
BR (1) BR7205069D0 (fi)
CA (1) CA982148A (fi)
CH (1) CH574397A5 (fi)
CS (1) CS171171B2 (fi)
DD (1) DD101389A5 (fi)
DK (1) DK142843B (fi)
ES (1) ES404739A1 (fi)
FI (1) FI55492C (fi)
FR (1) FR2147277B1 (fi)
GB (1) GB1374367A (fi)
HU (1) HU163818B (fi)
IE (1) IE36607B1 (fi)
NL (1) NL176254C (fi)
NO (1) NO137500C (fi)
PL (1) PL84891B1 (fi)
SE (1) SE399702B (fi)
SU (1) SU441704A3 (fi)
ZA (1) ZA724512B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57182525U (fi) * 1981-05-15 1982-11-19
JPH01128053U (fi) * 1988-02-24 1989-08-31
JP2514855B2 (ja) * 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
GB2267709A (en) * 1992-06-11 1993-12-15 Merck & Co Inc Novel process for the preparation of alpha-aminoacylanilides
WO2011006073A1 (en) 2009-07-10 2011-01-13 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
DE102012210082A1 (de) * 2012-06-15 2013-12-19 Hilti Aktiengesellschaft Werkzeugmaschine und Steuerungsverfahren
AU2016301282B2 (en) 2015-08-03 2022-03-17 Children's Medical Center Corporation Charged ion channel blockers and methods for use
JP2022527690A (ja) 2019-03-11 2022-06-03 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MA55320A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques substitués par un ester et méthodes d'utilisation
EP3937945A4 (en) 2019-03-11 2023-01-04 Nocion Therapeutics, Inc. CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN114828845A (zh) 2019-11-06 2022-07-29 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
JP2023517604A (ja) 2020-03-11 2023-04-26 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法

Also Published As

Publication number Publication date
CH574397A5 (fi) 1976-04-15
DE2235745B2 (de) 1976-08-19
AU4488672A (en) 1974-01-31
HU163818B (fi) 1973-11-28
BR7205069D0 (pt) 1973-07-17
BE786875A (fr) 1973-01-29
FR2147277A1 (fi) 1973-03-09
CS171171B2 (fi) 1976-10-29
DE2235745A1 (de) 1973-02-22
IE36607B1 (en) 1976-12-08
DK142843C (fi) 1981-08-31
NL176254B (nl) 1984-10-16
FR2147277B1 (fi) 1976-04-16
ES404739A1 (es) 1975-07-16
AT317185B (de) 1974-08-12
SE399702B (sv) 1978-02-27
DD101389A5 (fi) 1973-11-05
AR193748A1 (es) 1973-05-22
IE36607L (en) 1973-01-28
GB1374367A (en) 1974-11-20
DK142843B (da) 1981-02-09
SU441704A3 (ru) 1974-08-30
FI55492B (fi) 1979-04-30
FI55492C (fi) 1979-08-10
NL7210418A (fi) 1973-01-30
ZA724512B (en) 1973-08-29
NL176254C (nl) 1985-03-18
AU476000B2 (en) 1976-09-09
NO137500B (no) 1977-11-28
PL84891B1 (en) 1976-04-30
CA982148A (en) 1976-01-20
JPS565220B1 (fi) 1981-02-04

Similar Documents

Publication Publication Date Title
SE405604B (sv) Analogiforfarande for framstellning av 1,2,4-triazol-3-karboxamid-1-(beta-d-ribofuranosyl)
NO137092C (no) Analogifremgangsm}te til fremstilling av anthelmintisk virksomme 2-karbalkoksyamino-benzimidazol-5(6)-fenyletere
SE408179B (sv) Analogiforfarande for framstellning av imidazo(5,1-a)-as-triaziner
NO136793C (no) Analogifremgangsm}te til fremstilling av terapeutisk virksomme substituerte 1,2,4-triazolderivater.
NO137500C (no) Analogifremgangsmaate til fremstilling av 2-amino-2`, 6`-propion-xylidid til bruk som legemiddel mot hjerte-arytmi
NO138374C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO740606L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser.
SE385895B (sv) Forfarande for framstellning av mononitratestrar av 1,4:3,6-dianhydro-
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
DK136612C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-4-pregnen-21-syrederivater
NO136092C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktiv 4-(4-bifenyl)-1-butanol.
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
NO740607L (no) Analogifremgangsmåte til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser.
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE398501B (sv) Analogiforfarande for framstellning av 1,4-bensodiazepinderivat
NO137093C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner
NO140104C (no) Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
NO136198C (no) Analogifremgangsm}te ved fremstilling av terapeutisk aktivt 16-carboxy-17-methoxy-eburnan.
SE425250B (sv) Forfarande for framstellning av vermherdande fenolformaldehydhartser.
NO136495C (no) Analogifremgangsm}te til fremstilling av en terapeutisk aktiv dibenzoksirenazepinforbindelse